TickerFacts.

Enveric Biosciences, Inc. (ENVB): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$431.4K
As of 2019-12-31
-32.1%
3-year compound annual growth
n/m
5-year compound annual growth
$4.88M2010-12-31: $1.1K2011-12-31: $18.2K2012-12-31: $1.4K2013-12-31: $2492014-12-31: $5.1K2015-12-31: $1.88M2016-12-31: $1.38M2017-12-31: $4.88M2018-12-31: $1.37M2019-12-31: $431.4K$431.4K
2010-12-31 Cash & Equivalents (USD) 2019-12-31
Period endedCash & EquivalentsChange YoYSource filing
2019-12-31$431.4K-68.5%2020-08-12, Balance as of period end
2018-12-31$1.37M-71.9%2020-08-12, Balance as of period end
2017-12-31$4.88M+253.8%2019-03-26, Balance as of period end
2016-12-31$1.38M-26.5%2018-04-02, Balance as of period end
2015-12-31$1.88Mn/m2017-04-04, Balance as of period end
2014-12-31$5.1Kn/m2015-03-31, Balance as of period end
2013-12-31$249-82.0%2015-03-31, Balance as of period end
2012-12-31$1.4K-92.4%2014-03-28, Balance as of period end
2011-12-31$18.2Kn/m2013-02-28, Balance as of period end
2010-12-31$1.1Kn/a2012-03-07, Balance as of period end